Effect of prenatal high-dose vitamin D on childhood atopic dermatitis is modified by maternal cotinine metabolome: A secondary analysis of a randomized clinical trial
Journal of the American Academy of Dermatology · 2026-01 · 94 (1) · 88-95
DOI: 10.1016/j.jaad.2025.08.044 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026-01. Verfasst von Nicklas Brustad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Electronic addres…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Vitamin D, Prenatal Exposure Delayed Effects, Cotinine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, European Research Council, Lundbeckfonden.
Abstract (Originalsprache)
BACKGROUND: Tobacco exposure has been shown to modulate the effect of vitamin D on the risk of atopic diseases. However, randomized clinical trials investigating the potential effect modification between tobacco exposure and vitamin D supplementation on atopic disease risk are lacking. OBJECTIVE: We sought to investigate the potential effect modification from maternal tobacco exposure on the effect of prenatal high-dose vitamin D supplementation on the risk of child atopic dermatitis, asthma, and allergic rhinitis. METHODS: A post hoc analysis in the double-blinded COPSAC2010 randomized clinical trial (NCT00856947) including 581 mother-child pairs randomized to 2800 IU/d (high-dose) versus 400 IU/d (standard-dose) from pregnancy week 24. Maternal blood metabolomic profiling was performed at inclusion, reflecting maternal tobacco exposure using a supervised sparse partial least squares model. RESULTS: We found a significant effect modification from the maternal cotinine metabolome score (Pinteraction < .01) where high-dose vitamin D reduced atopic dermatitis until the age of 6 years in offspring from mothers with highest (fourth quartile) cotinine metabolome score: crude; hazard ratio = 0.46 (0.23-0.93), P = .03, and adjusted for sex, birth season, socioeconomic circumstances, living environment, air pollution, maternal diet, vitamin D levels, and fish oil intervention; hazard ratio = 0.36 (0.15-0.85), P = .02. Similarly, significant effect modification was demonstrated on the risk of asthma (Pinteraction = .03) until the age of 6 years but not allergic rhinitis (Pinteraction = .08) at the age of 6 years. CONCLUSIONS: This exploratory study of prespecified randomized clinical trial outcomes demonstrates effect modifications of the maternal tobacco exposure metabolome on the primary preventive effect of prenatal high-dose vitamin D on offspring atopic disease risk, suggesting a potential personalized prevention strategy targeting mothers exposed to tobacco smoking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Electronic address: nicklas.brustad@dbac.dk.
- Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Copenhagen, Denmark.
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Food Science, University of Copenhagen, Copenhagen, Denmark.
- Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of…
Förderung
- Horizon 2020 Framework Programme
- European Research Council
- Lundbeckfonden
Zitieren
APA
Brustad, N., Wang, T., Chen, L., Kaiser, H., Gomes, B., Klein, A., Vahman, N., Skov, L., Stokholm, J., Schoos, A. M., Bønnelykke, K., & Chawes, B. (2026). Effect of prenatal high-dose vitamin D on childhood atopic dermatitis is modified by maternal cotinine metabolome: A secondary analysis of a randomized clinical trial. Journal of the American Academy of Dermatology, 94(1), 88-95. https://doi.org/10.1016/j.jaad.2025.08.044
Vancouver
Brustad N, Wang T, Chen L, Kaiser H, Gomes B, Klein A, et al. Effect of prenatal high-dose vitamin D on childhood atopic dermatitis is modified by maternal cotinine metabolome: A secondary analysis of a randomized clinical trial. Journal of the American Academy of Dermatology. 2026;94(1):88-95. doi:10.1016/j.jaad.2025.08.044
BibTeX
@article{Brustad2026,
author = {Brustad, Nicklas and Wang, Tingting and Chen, Liang and Kaiser, Hannah and Gomes, Beatriz and Klein, Amalie and Vahman, Nilo and Skov, Lone and Stokholm, Jakob and Schoos, Ann-Marie and Bønnelykke, Klaus and Chawes, Bo},
title = {Effect of prenatal high-dose vitamin D on childhood atopic dermatitis is modified by maternal cotinine metabolome: A secondary analysis of a randomized clinical trial},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {94},
number = {1},
pages = {88--95},
doi = {10.1016/j.jaad.2025.08.044}
}
EUVIMED